Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fate Therapeutics
University of Arizona
Thomas Jefferson University
Eli Lilly and Company
Cedars-Sinai Medical Center
Celgene
Fate Therapeutics
Fate Therapeutics
M.D. Anderson Cancer Center
SCRI Development Innovations, LLC
Georgetown University
M.D. Anderson Cancer Center
Nevada Cancer Institute